文献速递其他结缔组织病

PROMIS身体功能表在特发性炎症性肌病中的效用研究

Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy.
PubMed 文献 · Semin Arthritis Rheum · 2021-04-15

结果显示PROMIS PF-20具有强重测信度、良好的收敛效度和反应性,变化与总改善评分(TIS)强相关;HAQ-DI存在天花板效应。

要点

  • PROMIS PF-20在IIM患者中显示强重测信度和良好收敛效度。
  • PROMIS PF-20变化与2016 ACR/EULAR肌炎反应标准的总改善评分强相关。
  • HAQ-DI和SF-36 PF10效度与反应性相似,但HAQ-DI存在天花板效应。

核心结论

  • PROMIS PF-20在较大样本的肌炎患者中展现出良好的心理测量学特性,并具有独特优势。

主要发现

  • PROMIS PF-20在1个月内重复测量显示强重测信度。
  • PROMIS PF-20与MD-GDA、PT-GDA、MMT、HAQ-DI、SF-36 PF10及功能测试呈中至强相关,表明良好的收敛效度。
  • PROMIS PF-20的变化与总改善评分(TIS)强相关,显示良好的反应性。
  • HAQ-DI和SF-36 PF10表现出相似的效度和反应性;HAQ-DI存在天花板效应。

关键数值与推荐

  • 2016 ACR/EULAR肌炎反应标准的总改善评分(TIS)用作变化测量指标。
  • 患者平均年龄51.6岁,女性占60%;包括6例多发性肌炎、24例皮肌炎、9例坏死性肌病和11例反合成酶综合征。

临床怎么用

  • PROMIS PF-20可作为评估IIM患者身体功能的有效工具,尤其适用于需要避免天花板效应的场景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Idiopathic inflammatory myopathies (IIM) are a group of diseases characterized by muscle weakness, which limit activities of daily living. Patient Reported Outcomes Measurement Information System (PROMIS) is a set of outcome measures developed using NIH funding, but has not yet been studied in adult IIM. Currently, the most commonly used PROs in IIM are Health Assessment Questionnaire (HAQ-DI) and SF-36 physical function-10 (PF10), both of which have several limitations. In this study, we investigated psychometric properties of PROMIS physical function-20 (PF-20) and compared to HAQ-DI and SF-36 PF10. METHODS: Patients with IIM completed PROMIS PF-20 and six myositis core set measures [manual muscle testing (MMT), physician (MD-GDA), patient (PT-GDA) and extra-muscular global disease activity, HAQ-DI and creatine kinase], SF-36 PF10 and functional tests [six-minute walk, timed up-and-go and sit-to-stand tests] at monthly visits over 6-months. Total improvement score (TIS) using 2016 ACR/EULAR myositis response criteria was obtained as measures of change. RESULTS: Fifty patients [mean age, 51.6; 60% females] were enrolled; 6 PM, 24 DM, 9 NM and 11 with AS. PROMIS PF-20 showed strong test-retest reliability when repeated in 1-month. PROMIS PF-20 had moderate-strong correlations with MD-GDA, PT-GDA, MMT, HAQ-DI, SF-36 PF10, and functional tests indicating good convergent validity. Change in PROMIS PF-20 strongly correlated with TIS demonstrating good responsiveness. HAQ-DI and SF-36 PF10 exhibited similar validity and responsiveness; HAQ-DI was found to have a ceiling effect. CONCLUSION: PROMIS PF-20 demonstrates favorable psychometric properties in a large cohort of myositis patients and offers distinct advantages.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Saygin D, Oddis CV, Dzanko S, et al. Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy. Semin Arthritis Rheum. 2021. PMID: 33894634. doi:10.1016/j.semarthrit.2021.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。